You are here: » Timelines » US Food and Drug Administration (FDA)

US Food and Drug Administration (FDA)

» Timelines » US Food and Drug Administration (FDA)

US Food and Drug Administration (FDA)

HQ Country
United States
Filtered by:
US Food and Drug Administration (FDA)
11 Apr

Medical start-up RxFunction Inc raises $7.5 million in Series A

Medical start-up RxFunction, Inc., a wearable technology company that created walkasins® - the first Wearable Sensory Prosthesis - has completed its Series A funding round, raising $7.5 million and surpassing the initial funding goal of $5 million.
9 Apr

Get immediate results with new blood test technology

Researchers have created a mobile version of the "Enzyme Linked Immunosorbent Assay" (ELISA), the gold standard technique used to detect the presence of an antibody or antigen. Instead of sending patients to a laboratory, new cell phone-based technology allows for the very same test to be conducted in the doctor's office, clinic or even in a remote area.
5 Apr

Advanced Wound Care Technologies 2018 - 2028

IDTechEx Report: Dr Nadia Tsao
4 Apr


IDTechEx interviewed Aleksandr Shtukater, founder of Raayonnova, about their progress developing smart contact lenses integrating displays.
4 Apr

Trial of first bioelectronic device to treat rheumatoid arthritis

A pilot trial for patients with drug refractory rheumatoid arthritis in the U.S. The multi-center study, "A Randomized Controlled Study of the Safety and Efficacy of Neurostimula- tion Using a Vagus Nerve Stimulation Device in Patients with Rheumatoid Arthritis," assesses the safety and efficacy of a proprietary bioelectronic device in adult patients with RA who are not adequately responsive to multiple biologic agents.
29 Mar

Haptics 2018-2028: Technologies, Markets and Players

IDTechEx Report: Mr James Hayward
28 Mar

Tissue Engineering and Regenerative Medicine

The aim of tissue engineering and regenerative medicine is to create living biological tissue that can repair and replace damaged tissues in the body, something that cannot be achieved by medicine and medical procedures.
16 Mar

Neuromodulation for migrane relief

electroCore, LLC has received clearance from the U.S. Food and Drug Administration for an expanded label for gammaCore as an acute treatment of pain associated with migraine in adult patients. gammaCore therapy is a proprietary, non-invasive neuromodulation treatment delivered by a hand-held unit that stimulates the vagus nerve through the skin.
14 Mar

CRISPR enhances cancer immunotherapy

Last year, the Food and Drug Administration approved the first cellular immunotherapies to treat cancer. These therapies involve collecting a patient's own immune cells -- called T cells -- and supercharging them to home in on and attack specific blood cancers, such as hard-to-treat acute lymphoblastic leukemia and non-Hodgkin lymphoma.
13 Mar

AI to help stroke victims

The U.S. Food and Drug Administration has granted a De Novo request for the first-ever Computer-Aided Triage and Notification Platform to identify Large Vessel Occlusion strokes in CTA imaging.
13 Mar

3D Bioprinting 2018 - 2028: Technologies, Markets, Forecasts

IDTechEx Report: Dr Nadia Tsao
12 Mar

Human-on-a-Chip: using tissue engineering to replicate the human body

An application of tissue engineering that is rapidly growing is the building of organ-on-a-chip devices.
6 Mar

Digital Health 2018: Trends, Opportunities and Outlook

IDTechEx Report: Dr Laura Baers
27 Feb

Implanted continuous glucose sensor proven safe

Results of the PRECISE II study showed the implanted continuous glucose monitoring (CGM) system from Eversense to be safe and highly accurate over the 90-day sensor life in patients with type 1 or type 2 diabetes.
27 Feb

Toxicant Materials and Alternatives in Electronics/ Electrics 2018-2028

IDTechEx Report: Dr Peter Harrop and Dr Lorenzo Grande
19 Feb

New Robotics and Drones 2018-2038: Technologies, Forecasts, Players

IDTechEx Report: Dr Khasha Ghaffarzadeh
10 Feb


IDTechEx analyst Nadia Tsao interviewed Histogenics CTO Stephen Kennedy on August 17, 2017. Histogenics is a regenerative medicine company focused on developing solutions for the musculoskeletal system.
6 Feb


IDTechEx analyst Nadia Tsao interviewed BellaSeno co-founder and CTO Dr Mohit Chhaya on 19 January 2018. BellaSeno is a preclinical company using 3D printing to create scaffolds for breast reconstruction.
26 Jan

Platoscience Neurostimulation

Platoscience Neurostimulation, based out of Copenhagen, unveiled several headsets designed to help users create or concentrate on a given task at CES 2018.
26 Jan


The Reliefband is a non-invasive, drug free device work on the wrist that provides gentle neuromodulation to the medial nerve.